Magnetar Capital

CoreWeave specializes in providing flexible compute services tailored for the CGI and machine learning industries. The company offers a specialized cloud infrastructure platform that delivers GPU-accelerated computing resources, enabling clients to enhance their workflows and efficiently handle complex models. With a robust hardware and systems management infrastructure, CoreWeave supports clients in scaling operations and adapting to changing compute demands while maintaining competitive pricing.

Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.

PosiGen CT, LLC sells and leases solar power systems, solar hot water systems, and energy efficiency upgrade solutions for residential and commercial users in Louisiana, New York, Connecticut, and Florida. It offers solar panel systems for heating, cooling, and illuminating homes and offices. The company also provides solar energy; energy efficiency audit services; and assess and permit, panel installation, and inspection services. The company was founded in 2011 and is based in Jefferson, Louisiana with additional offices in New York and Connecticut.

ViRB is a technology-enabled company based in Brookline, Massachusetts, founded in 2021. It specializes in sourcing, training, and deploying new clinical research professionals within the life sciences industry. The company aims to create a people-centric clinical trial ecosystem by providing a talent-as-a-service resource management platform. This platform addresses the gap between clinical research job opportunities and qualified candidates, ensuring that the healthcare sector has access to trained professionals ready to contribute to clinical trials.

CoreWeave specializes in providing flexible compute services tailored for the CGI and machine learning industries. The company offers a specialized cloud infrastructure platform that delivers GPU-accelerated computing resources, enabling clients to enhance their workflows and efficiently handle complex models. With a robust hardware and systems management infrastructure, CoreWeave supports clients in scaling operations and adapting to changing compute demands while maintaining competitive pricing.

Comtech Telecommunications Corp. designs, develops, produces and markets innovative products, systems and services for advanced communications solutions. Comtech has grown substantially in recent years. They believe they are well positioned for growth.

Activ Surgical Inc. is a Boston-based company focused on developing innovative solutions for robotic surgery. Founded in 2014, the company has created a robotic surgery platform that leverages advanced computer vision, artificial intelligence, and robotics to assist surgeons during complex procedures. Its flagship product, the Smart Tissue Autonomous Robot (STAR), aims to improve surgical outcomes by enhancing intraoperative decision-making and reducing the risk of unintended surgical errors. By utilizing a patent-protected surgical software platform, Activ Surgical strives to transform surgical vision and enable safer, more efficient surgeries through the integration of augmented reality and AI-driven technologies.

Benson Hill is an agricultural technology company focused on crop improvement, particularly in soy protein innovation. By leveraging its proprietary CropOS™ platform, the company integrates machine learning, genomic data, and traditional breeding techniques to streamline the development of healthier and more sustainable food products. Benson Hill emphasizes unlocking the natural genetic diversity of plants to empower innovators in creating flavorful and nutritious ingredients. The company operates a Crop Accelerator for rapid prototyping and is developing a diverse seed portfolio that includes protein ingredients, aquaculture, specialty animal feed, and vegetable oils. Its revenue is generated from both proprietary and non-proprietary product categories, reflecting its commitment to advancing agricultural innovation.

Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily. It was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Evolv Technology specializes in noninvasive body scanners designed for touchless security screening, focusing on enhancing safety in public spaces. The company offers a range of products, including Evolv Express for firearm and bomb detection, Evolv Edge for checkpoint security, and Evolv Pinpoint for facial recognition. These systems are utilized in various settings, such as schools, stadiums, hospitals, and entertainment venues, to ensure the safety of employees, visitors, and VIPs. Founded in 2013 and headquartered in Waltham, Massachusetts, Evolv Technology aims to improve security protocols by integrating advanced sensors and artificial intelligence, enabling reliable scanning without compromising the visitor experience. The company has screened over 50 million individuals, successfully preventing more than 5,000 weapons from entering secure areas. With a leadership team comprising veterans from security agencies, Evolv is committed to providing effective solutions for both government and private sectors.

OncoResponse Inc. is an immuno-oncology company based in Houston, Texas, focused on discovering new cancer immunotherapies and therapeutic antibodies. The company collaborates with MD Anderson Cancer Center to utilize the I-STAR™ platform, which analyzes the human memory B-cell repertoire of patients who have demonstrated exceptional responses to immunotherapy, referred to as "Elite Responders." By studying these patients, OncoResponse aims to harness the human immune system to identify fully human monoclonal antibodies and novel targets. This approach is intended to facilitate the development of innovative antibody-derived therapeutics for cancer treatment.

Judo Bank Pty. Ltd., founded in 2016 and based in Southbank, Australia, specializes in providing lending services to small and medium enterprises (SMEs). The bank offers a range of financial products, including business loans, lines of credit, equipment loans, and finance leases. Recognizing the significant role that SMEs play in the Australian economy, Judo Bank aims to address the financial needs of these businesses by offering personalized banking solutions. Customers benefit from direct interactions with empowered decision-makers, ensuring that each application is evaluated based on its unique circumstances rather than standardized metrics. This relationship-focused approach allows Judo Bank to tailor its services to meet the specific needs of its clients, fostering a supportive environment for the growth and success of small to medium-sized businesses.

Imvax, Inc. is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, focused on developing innovative patient-specific vaccines and immunotherapy strategies for treating malignant gliomas and other cancers that lack effective treatments. The company's lead product, IGV-001, is an autologous tumor cell vaccine designed to stimulate a robust immune response against tumor cells by utilizing the patient's own immune system. Imvax employs advanced methodologies, including patient cell harvest, treatment, and implants, as well as techniques that promote immunogenic cell death and activate both the innate and adaptive immune responses. Founded in 2015 by a team of experienced professionals, Imvax aims to address significant unmet medical needs in oncology through its novel therapeutic approaches.

Imvax, Inc. is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, focused on developing innovative patient-specific vaccines and immunotherapy strategies for treating malignant gliomas and other cancers that lack effective treatments. The company's lead product, IGV-001, is an autologous tumor cell vaccine designed to stimulate a robust immune response against tumor cells by utilizing the patient's own immune system. Imvax employs advanced methodologies, including patient cell harvest, treatment, and implants, as well as techniques that promote immunogenic cell death and activate both the innate and adaptive immune responses. Founded in 2015 by a team of experienced professionals, Imvax aims to address significant unmet medical needs in oncology through its novel therapeutic approaches.

Exo is a medical device startup handheld ultrasound platform and AI for imaging and therapeutic applications. The company is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high-quality medical imaging. Exo empowers healthcare professionals to make critical, real-time decisions that improve patient outcomes. The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging. It also represents a giant leap in imaging and therapeutics technology one that will drive the development of high-performance products that are accessible, easy-to-use, and available at a price point never before possible.

Lucid Energy Group is a midstream services company based in Dallas, Texas, specializing in natural gas gathering, processing, transportation, and treatment for producers in the Permian Basin. Established in 2011 with backing from EnCap Flatrock Midstream, Lucid focuses on expanding its gathering and processing facilities in key production areas such as the Wolfcamp and Clines shales. The company operates field offices in Sterling City and San Angelo to support its operations on the Eastern Shelf of the Permian Basin. Lucid Energy Group is committed to developing both large and small-scale infrastructure and facilities related to crude oil production, aiming to address the increasing demand for midstream services in the region. By prioritizing customer service and fostering clear communication, Lucid strives to provide tailored solutions that build trust and ensure successful partnerships with its clients.

Fountainhead is a provider of direct commercial lending services focused on assisting small and midsized business owners in achieving wealth through commercial real estate ownership. The company specializes in offering commercial real estate loans, including Small Business Administration (SBA) 504 loans and low loan-to-value conventional loans. By streamlining the lending process, Fountainhead enables business owners to make quick credit decisions and facilitate fast closings, addressing the common financial barriers that prevent them from purchasing commercial property. This approach allows business owners to invest in real estate, which is recognized as a valuable long-term asset, enhancing their overall net worth.

SurgRx, Inc is a developer of laparoscopic vessel fusion tools for surgical hemostasis. The company develops tissue sealing and hemostasis systems for laparoscopic and open surgery. It also offers EnSeal, a tissue sealing and hemostasis system that allows surgeons to seal and transect vessels, pedicles, and tissue bundles to achieve surgical hemostasis. SurgRx, Inc is based in Redwood City, California.

Kintera is leader and pioneering provider of Software as a Service (SaaS) solutions to the nonprofit and government sectors. They are a leading provider of software that enables nonprofit organizations to use the Internet to bring their employees, volunteers and donors together in online, interactive communities that increase donations, reduce fundraising costs and build affinity for an organization's cause.